RxDoctor Payments Data

Mark Gillespy, MD

Orthopaedic Surgery · Daytona Beach, FLNPI 1073592606

Payments from drug & device makers

$124,045in general payments, 2019–2025

Across 69 payments — averaging $1797.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Providence Medical Technology, Inc.$63K
  • Limacorporate S.p.a.$55K
  • Depuy Synthes Products, Inc.$3K
  • Solco Biomedical Corporation$1K
  • Surgalign Spine Technologies, Inc.$600
  • Abbott$223
  • plus $689 from 11 others
$26,182in research payments, 2019–2025

Across 73 payments — averaging $358.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Limacorporate S.p.a.$24K
  • Lima USA, Inc.$3K

What the payments were for

  • Consulting fees$4,23868%
  • Travel & lodging$63710%
  • Food & beverage$1,38422%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$124,045 in reported general payments places this provider in the 85th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$314,947
Medicare patients
564
Services billed
3,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen186$1,864
Meloxicam381$1,780
Celecoxib130$829
Cefadroxil48$455
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen20$253
Prednisone34$156
Amoxicillin55$145
Diclofenac Sodium12$123
Gabapentin17$119
Tramadol Hcl13$38

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Daytona Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →